Isotopen Technologien Munchen Competitors and Similar CompaniesClear all
Isotopen Technologien Munchen's competitors and similar companies include BioInvent and Pharma Mar.
 Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. |  Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs. | ||
Founding Date | Founding Date 2004 | Founding Date 1997 | Founding Date 1986 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Garching bei München, DE HQ München, DE | Locations Lund, SE HQ | Locations Colmenar Viejo, ES HQ Madrid, ES |
Employees | Employees 5403% increase | Employees 118 | Employees 500 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 285.9 m | Valuation ($) 1.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) €221.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €12.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit kr226.6m (FY, 2025) | Gross profit €232m (FY, 2025) |
Net income | Net income N/A | Net income (kr332.9m) (FY, 2025) | Net income €75m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
BioInvent
HQ
Lund, SE
Employees
118
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View companyPharma Mar
HQ
Colmenar Viejo, ES
Employees
500
Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.
View company